Cleland JG - Search Results

1

Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study.

Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, Hillege H, Samani NJ, Zannad F, Dickstein K, Lang CC, Cleland JG, Ter Maaten JM, Metra M, Anker SD, van der Harst P, Ng LL, van der Meer P, van Veldhuisen DJ, Meyer S, Lam CSP; ASIAN-HF investigators; Voors AA. Santema BT, et al. Among authors: cleland jg. Lancet. 2019 Oct 5;394(10205):1254-1263. doi: 10.1016/S0140-6736(19)31792-1. Epub 2019 Aug 22. Lancet. 2019. PMID: 31447116 Free article.

2

Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure.

Moore DP, Weston AR, Hughes JM, Oakley CM, Cleland JG. Moore DP, et al. Among authors: cleland jg. Lancet. 1992 Apr 4;339(8797):850-3. doi: 10.1016/0140-6736(92)90288-e. Lancet. 1992. PMID: 1347866 Clinical Trial.

3

ACE inhibitors in mild heart failure: first-line or second-line therapy?

Cleland JG. Cleland JG. Eur Heart J. 1990 May;11 Suppl D:53-7. doi: 10.1093/eurheartj/11.suppl_d.53. Eur Heart J. 1990. PMID: 2193811 Review.

4

Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism?

Habib F, Dutka D, Crossman D, Oakley CM, Cleland JG. Habib F, et al. Among authors: cleland jg. Lancet. 1994 Aug 6;344(8919):371-3. doi: 10.1016/s0140-6736(94)91402-8. Lancet. 1994. PMID: 7914308

5

Carvedilol for heart failure, with care.

Cleland JG, Swedberg K. Cleland JG, et al. Lancet. 1996 May 4;347(9010):1199-201. doi: 10.1016/s0140-6736(96)90729-1. Lancet. 1996. PMID: 8622445 No abstract available.

6

What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity.

Narang R, Swedberg K, Cleland JG. Narang R, et al. Among authors: cleland jg. Eur Heart J. 1996 Jan;17(1):120-34. doi: 10.1093/oxfordjournals.eurheartj.a014670. Eur Heart J. 1996. PMID: 8682118 Review.

7

Beta-blocking agents in heart failure. Should they be used and how?

Cleland JG, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F. Cleland JG, et al. Eur Heart J. 1996 Nov;17(11):1629-39. doi: 10.1093/oxfordjournals.eurheartj.a014745. Eur Heart J. 1996. PMID: 8922910 Review.

8

Effect of ramipril on morbidity and mode of death among survivors of acute myocardial infarction with clinical evidence of heart failure. A report from the AIRE Study Investigators.

Cleland JG, Erhardt L, Murray G, Hall AS, Ball SG. Cleland JG, et al. Eur Heart J. 1997 Jan;18(1):41-51. Eur Heart J. 1997. PMID: 9049514 Clinical Trial.

9

From left ventricular dysfunction to heart failure.

Cleland JG. Cleland JG. Arch Mal Coeur Vaiss. 1996 Nov;89(11):1397-402. Arch Mal Coeur Vaiss. 1996. PMID: 9092398 Review.

10

Combination drug therapy in chronic heart failure: is treatment part of the problem in heart failure?

Cleland JG. Cleland JG. Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:297-303. doi: 10.1023/a:1007700215917. Cardiovasc Drugs Ther. 1997. PMID: 9211024 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,135 results

Search Page